Sensei Biotherapeutics, Inc. (SNSE) — 10-Q Filings
All 10-Q filings from Sensei Biotherapeutics, Inc.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Sensei Narrows Q2 Loss Amid R&D Cuts, Cash Dwindles
— Aug 5, 2025 Risk: high
Sensei Biotherapeutics, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with its clinical-stage status. The company posted -
Sensei Biotherapeutics Files Q1 2025 10-Q
— May 6, 2025 Risk: medium
Sensei Biotherapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first -
Sensei Biotherapeutics Files Q3 2024 10-Q
— Nov 14, 2024 Risk: medium
Sensei Biotherapeutics, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates. Key fina -
Sensei Biotherapeutics Files Q2 2024 10-Q
— Aug 6, 2024 Risk: medium
Sensei Biotherapeutics, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial results and provided updates on its business -
Sensei Biotherapeutics Files 10-Q for Period Ending March 31, 2024
— May 9, 2024 Risk: medium
Sensei Biotherapeutics, Inc. (SNSE) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Sensei Biotherapeutics, Inc. filed a 10-Q report for the quarte
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX